Opthea Ltd
CYVNY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815620
No open-market purchases or sales by Opthea Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCKDXF
13F holders, Q1 2025
Institutional positions in Opthea Ltd as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −2 vs. Q4 2024
- Shares held
- 7.51M
- +2.11M (+39.1%) vs. Q4 2024
- Total value
- $613.4K
- −$20.6M (−97.1%) vs. Q4 2024
- New holders
- 1
- 3 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYVNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $64.2K |
| Q2 2025 | 8 | $393.2K |
| Q1 2025 | 9 | $613.4K |
| Q4 2024 | 11 | $21.2M |
| Q3 2024 | 7 | $21.3M |
| Q2 2024 | 9 | $12.2M |
| Q1 2024 | 8 | $27.5M |
| Q4 2023 | 11 | $21.1M |
| Q3 2023 | 9 | $12.7M |
| Q2 2023 | 9 | $20.7M |
| Q1 2023 | 12 | $29.9M |
| Q4 2022 | 9 | $41.3M |
| Q3 2022 | 9 | $50.1M |
| Q2 2022 | 8 | $50.7M |
| Q1 2022 | 8 | $33.7M |
| Q4 2021 | 9 | $42.5M |
| Q3 2021 | 8 | $46.0M |
| Q2 2021 | 9 | $45.6M |
| Q1 2021 | 8 | $54.2M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Opthea Ltd; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 105,939 | $356.0K | 0.00% | −36,576−25.7% | Reduced |
| Twin Lakes Capital Management, LLC | 33,156 | $113.1K | 0.08% | +13,350+67.4% | Added |
| Millennium Management LLC | 48,329 | $81.2K | 0.00% | −12,772−20.9% | Reduced |
| EP Wealth Advisors, LLC | 10,000 | $34.1K | 0.00% | +10,000 | New |
| UBS Group AG | 7,773 | $26.5K | 0.00% | −28,984−78.9% | Reduced |
| Morgan Stanley | 765 | $2.61K | 0.00% | −2,600−77.3% | Reduced |
| VGI Partners Ltd | 5,193,688 | $0 | 0.00% | +2,286,285+78.6% | Added |
| Baker Bros. Advisors LP | 2,087,320 | $0 | 0.00% | −86,302−4.0% | Reduced |
| Old Mission Capital LLC | 19,167 | $0 | 0.00% | +8,439+78.7% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,998−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,311−100.0% | Sold out |
| Abc Arbitrage SA | 0 | $0 | 0.00% | −10,216−100.0% | Sold out |